top of page

Meet the Speakers - ASM 2023

We have great pleasure in introducing our speakers for the Annual Scientific Meeting for 2023. Please find out about them below. 


Professor Cyprian Mendonca

Cyprian Mendonca is a consultant anaesthetist at University Hospitals Coventry & Warwickshire NHS Trust and an Honorary Professor at the University of Warwick. He is the current President of the Society for Education in Anaesthesia (SEA UK).


His special interests include head & neck anaesthesia, airway management, neuro anaesthesia, human factors and medical education. He is an academic lead for core clinical education at Warwick Medical School. He is the course director for human factors and airway training courses at Coventry. He has organised and successfully delivered several national educational events including advanced airway management and human factors and patient safety courses.


He has co-authored six books in anaesthesia and written chapters in anaestheisa textbooks. He has published a series of peer reviewed papers in advanced airway management and education.

He was awarded President’s commendation certificate from Royal College of Anaesthetists in 2016 and 2021, Featherstone Professor from Association of Anaesthetists (2016-18), and DAS Professor of Annaesthesia and Airway management in 2022 for his sustained contribution to education, airway management and research in Anaesthesia.

IMG_9631 2.jpeg

Dr Vishal Patil

Vishal Patil is a Consultant Anaesthesiologist at Cambridge University Hospitals NHS Foundation Trust.


He trained in India and following completion of post-graduate training in anaesthesiology (MD) came to the UK in 1995.


He was appointed as a Consultant in Cambridge in 2004.


His clinical interests are transplant anaesthesia, and anaesthesia for HPB and urological onco-surgery.


He has a long-standing interest in patient safety and quality.


He is an author of the Royal College of Anaesthetists Guidelines for the Provision of Anaesthetic Services for Perioperative Care of Elective and Urgent Care Patients, and an Anaesthesia Clinical Services Accreditation (ACSA) Reviewer for the Royal College of Anaesthetists.


He is the Regional Lead for the Safe Anaesthesia Liaison Group, a collaborative project between the Association of Anaesthetists, Royal College of Anaesthetists and NHS England/ NHS Improvement patient safety team.


He is the Regional Co-lead for the Royal College of Anaesthetists Quality Improvement Network.


In his free time, he enjoys theatre, travelling, and contemporary art.

Mark Slack.jpg

Dr Mark Slack

Mark qualified as a doctor at the University of the Witwatersrand in South Africa. He then completed his postgraduate training at the University of Cape Town. He graduated as a specialist Obstetrician & Gynaecologist from the College of Medicine of South Africa winning the Daubenton Gold Medal for the most distinguished candidate in the exams in the country.


He was previously head of Gynaecology and Urogynaecology at Addenbrooke’s Hospital, University of Cambridge Teaching Hospitals Trust, Cambridge. He is an associate Professor at the University of Cambridge.


Mr Slack has run an active research unit in Cambridge. The unit was involved in a number of research initiatives. He developed and introduced the Sacrospinous Fixation to the UK which is now the most performed procedure for the management of uterovaginal prolapse in the UK. In addition, he has invented several procedures which were adopted and taken to global launch by international Medical Device companies. Two by Johnson & Johnson. He has published over 100 peer reviewed papers, more than 25 book chapters and numerous national guidelines. He is a regular contributor on a number of National Radio and Television programs including “case notes, “Women’s Hour”, The Victoria Derbyshire show and regional and National news programs. He was one of the keynote speakers at the 2020 “WIRED” symposium, alongside the inventors of the COVID vaccine and the winner of the 2020 Nobel prize for medicine.


He was appointed the Ethicon travelling Professor in 2004 as well as the Sims Black Professorship of the Royal College of Obstetricians and Gynaecologists for 2005/6. Between 2006 and today he was awarded travelling Professorships to the Royal Australian and New Zealand College of Obstetrics and Gynaecology (2006 and 2019), the South African Medical college 2017, the University of Cape Town 2009, the University of British Columbia, Canada 2018 and the University of Pretoria 2018. He was recognised by the NIHR in 2015 with an award as one of the leading researchers in the UK for clinical research. In 2018, under his leadership the Urogynaecology unit in Cambridge achieved the highest accreditation score ever awarded by the Royal College of Obstetricians and Gynaecologists recognizing it as one of the leading units in the country.


He is a Co-founder and Chief Medical Officer of CMR Surgical, a start-up company in Cambridge which has developed a novel surgical robot (Versius). This is a next generation surgical robotic system designed to increase the use of minimally invasive (keyhole) surgery. This is now one of the largest Med Tech Start-Up companies in Europe and has recently had the highest private MedTech funding round in the world with a $660 million raise. The company currently employs more than 800 people in more than 7 geographies and has a valuation of $3.5 Billion. Mark is keen to stress the ethical manner that the company has brought the product to market alongside a range of other innovations including virtual reality training. He is also really proud of the digital innovations introduced by the company including a novel registry system to guarantee surgical safety.


In 2022 he was awarded an Honorary Fellowship by the Royal College of Physicians and Surgeons of Glasgow in recognition for his work in Medicine.


Dr Andrew Klein

Dr Andrew Klein is a Cardiothoracic Anaesthetist at Royal Papworth Hospital in Cambridge. He is the Editor-in-Chief of Anaesthesia, which has an Impact Factor of 13 and is the number one journal in the world for anaesthesia, peri-operative medicine and pain.


Andrew is on the Board and Council of the Association of Anaesthetists, the membership organisation for > 11,000 anaesthetists in Great Britain and Ireland. He sits on the Board and Council of the National Institute of Academic Anaesthesia (NIAA), which manages research grant funding in the UK.


Andrew’s main research areas are high-flow nasal oxygen to improve recovery after major surgery and pre-operative anaemia and the effects of iron replacement therapy. Andrew was the Royal College Macintosh Professor in 2020 and was a College examiner for eight years. Andrew is a keen cricket supporter and member of the Marylebone Cricket Club (MCC) at Lord’s in London, and a lifelong and long-suffering West Ham United season ticket holder.


Partha Kar

Professor Partha Kar is National Specialty Advisor, Diabetes; co-lead of the Getting it Right First Time (Diabetes) and Lead for the Medical Workforce Race Equality Standards with NHS England


He is an International Medical Graduate (India) who works as a Consultant in Diabetes & Endocrinology at Portsmouth Hospitals NHS Trust, UK since 2008- and won multiple awards at the BMJ, HSJ awards- apart from being recognised by the Kings Fund and NHS England for pioneering of the Super Six Diabetes Model which is recognised as one of the good examples of integrated care.

He has helped to expand use of technology in Type 1 Diabetes- namely use of Flash Glucose/CGM and implementation of use of CGM in T1D pregnancy along with use of online digital self-management platforms- while recently leading on real world data collection on Closed Loops for subsequent NICE review. He has worked subsequently with NICE on updating relevant guidelines in non-invasive glucose monitoring access in Type 1 and Type 2 Diabetes He has also led on championing Language Matters in Diabetes care


His other work has involved introduction of frailty into Quality Of Framework (QoF) treatment targets, Diabulimia pilot projects in the NHS; championing “Language Matters” and helping to create an overview of Diabetes care in Primary Care Networks. Recent work has focussed on transitional care models- as well as tackling inequalities in technology access based on deprivation & ethnicity

He is one of the leading users of social media in diabetes care- and writes a monthly blog for the British Medical Journal.

He has also been:


*Co-creator of TAD (Talking About Diabetes) – TED talks from those with T1Diabetes
*Co- creator of Type 1 Diabetes comic (Volume 1 to 4)

*Co-creator of DEVICES (Virtual Reality educational modules in diabetes)


Beyond diabetes, he also recently taken a role in tackling issues of racial disparity in the medical workforce as the Medical Workforce Race Equality Standard lead for NHS England.


Professor Kar has also been recognised as one of the most influential figures from the ethnic minority population across healthcare by the Healthcare Service Journal in 2020,2021 & 2022


Dr Simon Lambden

Dr Simon Lambden: Simon began his training in anaesthesia and intensive care medicine in the South East London, followed by a NIHR Academic Clinical Fellowship in North Central London and Imperial schools of anaesthesia.  He undertook fellowships in medical education in 2009 and in 2015 completed a PhD in vascular immunology at Imperial College, London.

He undertook his postdoctoral work as a NIHR clinical lecturer at Cambridge University whilst completing his clinical training in the East of England.  In parallel he spun out his first biotechnology company, Critical Pressure Ltd,  in 2016 to develop new therapies for diseases mediated by endothelial dysfunction.

Following CCT in 2019, Simon worked as a consultant in intensive care medicine at Cambridge University Hospitals NHS foundation trust.

Simon is currently the Chief Medical Office at Inotrem SA,  a Paris based biotech that is focussed on developing novel therapies targeting the TREM-1 pathway, an important regulator of the innate and endothelial immune response in acute and chronic inflammatory disease. He has recently completed two large multinational phase 2b trials in septic shock and severe COVID-19.

As a founder, leader and executive in a number of biotechnology companies, he has been part of teams that have secured more than €150million in funding to develop new treatments for diseases with large unmet clinical need and few existing treatment options.  His particular focus is on developing precision medicine strategies to combat the heterogeneity that has limited the number of new treatments to reach patients with acute inflammatory disease in the last two decades.


Dr Jennifer Taylor

Dr Jennifer Taylor:  "Jen Taylor has finally finished anaesthetic training after a long, and sometimes very difficult, journey through Yorkshire and the East Midlands. As many of you will relate to, she spent many years “funding her own wing” at the RCoA. She has recently been appointed to the post of Locum Consultant Anaesthetist at Stepping Hill Hospital in Stockport, and is working out her new life in the North West with her partner.


Her interests lie in education, simulation, and the shared decision making so important in perioperative medicine.


Out of work, she spends her time walking, caving, climbing, and baking gluten free cakes."

bottom of page